Inhibrx Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INBX and other ETFs, options, and stocks.About INBX
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function.
INBX Key Statistics
Stock Snapshot
Inhibrx Biosciences(INBX) stock is priced at $80.27, giving the company a market capitalization of 1.16B. It carries a P/E multiple of -7.84.
On 2026-02-25, Inhibrx Biosciences(INBX) stock traded between a low of $76.59 and a high of $82.58. Shares are currently priced at $80.27, which is +4.8% above the low and -2.8% below the high.
Inhibrx Biosciences(INBX) shares are trading with a volume of 234.18K, against a daily average of 169.13K.
During the past year, Inhibrx Biosciences(INBX) stock moved between $10.81 at its lowest and $94.57 at its peak.
During the past year, Inhibrx Biosciences(INBX) stock moved between $10.81 at its lowest and $94.57 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.